Timo Gaiser

10.5k citations
157 papers · 7.6k · 5 hit papers · h-index 36

Impact in

    • Gastric Cancer Management and Outcomes
  • Oncology top 2%
    • Colorectal Cancer Surgical Treatments
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
    • Cutaneous Melanoma Detection and Management

Papers in

Timo Gaiser

154 papers receiving 7.5k citations

Timo Gaiser's Hit Papers

Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial 2023 · 139 citations
1390+3+6Years since publication50010001.5k

Peers

Timo Gaiser
Comparison fields: 5 of 98
  • Pulmonary and Respiratory Medicine 1.6k
  • Oncology 1.1k
  • Artificial Intelligence 1.0k
  • Surgery 818
  • Cancer Research 208
Replace Meera Hameed with:
Meera Hameed United States
Robert Stoehr Germany
Julien Caldéraro France
Heike Irmgard Grabsch United Kingdom
Esther Herpel Germany
Alessandro Lugli Switzerland
Alexander Spyridon Baras United States
Katayoon Kasaian United States
Stefan M. Willems Netherlands
Joan Walker United States
Timo Gaiser relative to Meera Hameed United States Meera Hameed's profile →
Citations per field
00.5×1.5×1.9×
Meera Hameed · 1×
Citations per year

Countries citing papers authored by Timo Gaiser

Since Specialization
Citations

This map shows the geographic impact of Timo Gaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Gaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Gaiser more than expected).

Fields of papers citing papers by Timo Gaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Gaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Gaiser. The network helps show where Timo Gaiser may publish in the future.

Co-authors

The 25 scholars most cited alongside Timo Gaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timo Gaiser Line = papers co-authored together Timo Gaiser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Hit paper breakdown →
20191880
2
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study
Hit paper breakdown →
2019785
3
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Hit paper breakdown →
2016585
4
Multi-class texture analysis in colorectal cancer histology
Hit paper breakdown →
2016423
5 2010260
6 2021231
7 2018230
8 2013144
9
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
Hit paper breakdown →
2023139
10 2010108
11 2007102
12 201280
13 200979
14 201778
15 200974
16 202271
17 201370
18 202167
19 202266
20 201859

About Timo Gaiser

Timo Gaiser is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Artificial Intelligence, having authored 157 papers that have together received 7.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (17 papers), AI in cancer detection (12 papers), Genetic factors in colorectal cancer (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Colorectal Cancer Surgical Treatments (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (1.1k citations), Artificial Intelligence (1.0k citations), Surgery (818 citations) and Cancer Research (208 citations). Timo Gaiser has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Alexander Marx, Jakob Nikolas Kather, Cleo‐Aron Weis, Markus David Siegelin, Antje Habel, Daniela D. Hirsch, Susanne Melchers, Esther Herpel, Michael Hoffmeister and Hermann Brenner. Their work appears in journals such as International Journal of Cancer, European Journal of Cancer, Annals of Oncology, Oncotarget and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact